General Hospital Psychiatry
Volume 27, Issue 4 , Pages 237-243 , July 2005

Medical illness and response to treatment in primary care panic disorder

  • Peter Roy-Byrne, M.D.

      Affiliations

    • Department of Psychiatry and Behavioral Science, University of Washington School of Medicine at Harborview Medical Center, WA 98104, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 206 341 4201; fax: +1 206 731 3236.
    • ,
  • Murray B. Stein, M.D., M.P.H.

      Affiliations

    • Department of Psychiatry, University of California, San Diego, CA, USA
    • Department of Family and Preventive Medicine, University of California, San Diego, CA, USA
    • ,
  • Joan Russo, Ph.D.

      Affiliations

    • Department of Psychiatry and Behavioral Science, University of Washington School of Medicine at Harborview Medical Center, WA 98104, USA
    • ,
  • Michelle Craske, Ph.D.

      Affiliations

    • Department of Psychology, University of California, Los Angeles, CA, USA
    • ,
  • Wayne Katon, M.D.

      Affiliations

    • Department of Psychiatry and Behavioral Science, University of Washington School of Medicine, Seattle, WA 98104, USA
    • ,
  • Greer Sullivan, M.D., M.S.P.H.

      Affiliations

    • VA South Central Mental Illness Research Education and Clinical Center (MIRECC), Little Rock, AR, USA
    • University of Arkansas for Medical Science, Little Rock, AR, USA
    • ,
  • Cathy Sherbourne, M.D.

      Affiliations

    • The RAND Corporation, Santa Monica, CA, USA

Received 9 February 2005 ,Revised 16 March 2005 ,Accepted 21 March 2005.

References 

  1. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995;52:89–99
  2. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54:227–240
  3. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54:376–387
  4. Katon W, von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004;27:914–920
  5. Petitto JM, Evans DL. Depression in cancer and HIV infection: research findings and implications of effective antidepressant treatment. Depress Anxiety. 1998;8(Suppl 1):80–84
  6. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226
  7. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry. 2003;54:208–215
  8. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–3285
  9. Iosifescu DV, Nierenberg AA, Alpert JE, et al. The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry. 2003;160:2122–2127
  10. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry. 1997;12:817–824
  11. Oslin DW, Datto CJ, Kallan MJ, et al. Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc. 2002;50:823–828
  12. Koike AK, Unutzer J, Wells KB. Improving the care for depression in patients with comorbid medical illness. Am J Psychiatry. 2002;159:1738–1745
  13. Small GW, Birkett M, Meyers BS, et al. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine collaborative study group. J Am Geriatr Soc. 1996;44:1220–1225
  14. Papakostas GI, Petersen T, Iosifescu DV, et al. Axis iii disorders in treatment-resistant major depressive disorder. Psychiatry Res. 2003;118:183–188
  15. Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–435
  16. Walker EA, Katon W, Russo J, et al. Health care costs associated with posttraumatic stress disorder symptoms in women. Arch Gen Psychiatry. 2003;60:369–374
  17. Roy-Byrne P, Craske M, Stein M, et al. A randomized effectiveness trial of cognitive behavior therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005;62:290–298
  18. Craske MG, Roy-Byrne PP, Stein MB, et al. Treating panic disorder in primary care: a collaborative care intervention. Gen Hosp Psychiatry. 2002;24:148–155
  19. Roy-Byrne P, Sherbourne CD, Craske MG, et al. Moving treatment research from clinical trials to the real world: the design of a first-generation effectiveness study for panic disorder. Psychiatr Serv. 2003;54:288–300
  20. Barlow DH, Craske MG. Mastery of your anxiety and panic. 3rd ed.. Albany (NY): Graywind Publication; 2000;
  21. Barlow DH, Craske MG. Agoraphobia supplement. 3rd ed.. Albany (NY): Graywind Publication; 2000;
  22. Roy-Byrne PP, Stein MS, Bystrisky A, Katon W. Pharmacotherapy of panic disorder: proposed guidelines for the family physician. J Am Board Fam Pract. 1998;11:282–290
  23. Sloan KL, Sales AE, Liu CF, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41:761–774
  24. Wells KB. The design of partners in care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol. 1999;34:20–29
  25. Sales AE, Liu CF, Sloan KL, et al. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Med Care. 2003;41:753–760
  26. Otto MW, Reilly-Harrington N. The impact of treatment on anxiety sensitivity. In:  Taylor S editors. Anxiety sensitivity: theory, research, and treatment of the fear of anxiety. Mahwah, NJ: Erlbaum, Lawrence; 1999;p. 321–336
  27. Schmidt NB, Lerew DR, Joiner TE. Prospective evaluation of the etiology of anxiety sensitivity: test of a scar model. Behav Res Ther. 2000;38:1083–1095
  28. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401
  29. Epping-Jordan J, Usten T. The WHODAS II: level the playing field for all disorders. WHO Bull Mental Health. 2000;6:5–6
  30. Stein MB, Sherbourne CD, Craske MG, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry. 2004;161:2230–2237
  31. Steketee G, Perry JC, Goisman RM, et al. The psychosocial treatments interview for anxiety disorders. A method for assessing psychotherapeutic procedures in anxiety disorders. J Psychother Pract Res. 1997;6:194–210

PII: S0163-8343(05)00043-5

doi: 10.1016/j.genhosppsych.2005.03.007

General Hospital Psychiatry
Volume 27, Issue 4 , Pages 237-243 , July 2005

Article Tools

* Image Usage & Resolution